Quick Takeaways
- Adage Capital Management, L.P. filed SCHEDULE 13G for Inovio Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (INO).
- Disclosed ownership: 10%.
- Date of event: 30 Sep 2025.
Adage Capital Management, L.P. - 30 Sep 2025 SCHEDULE 13G Report for Inovio Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (INO)
- Filing Manager
- Adage Capital Management, L.P.
- Reporting Manager
- Adage Capital Management, L.P.
- Symbol
- INO
- Shares outstanding
- 55,231,732 shares
- Disclosed Ownership
- 5,517,650 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Nov 2025, 09:16:13 UTC
- Date of event
- 30 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Adage Capital Management, L.P. disclosed 10% ownership in Inovio Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (INO) on 30 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Nov 2025, 09:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Adage Capital Management, L.P. | 10% | 5,517,650 | 0 | 5,517,650 | /s/ Robert Atchinson | By: Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member | |
| Robert Atchinson | 10% | 5,517,650 | 0 | 5,517,650 | /s/ Robert Atchinson | Robert Atchinson, individually | |
| Phillip Gross | 10% | 5,517,650 | 0 | 5,517,650 | /s/ Phillip Gross | Phillip Gross, individually |